Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
Poster available until
  • Monday 29 June 2026 (373)
  • Tuesday 15 December 2026 (1)
  • x Until platform closure (793)
Poster categories
  • e-Thematic Poster Session (60)
  • Thematic Poster Session (733)
keywords
Session Reference
  • L-TPS01 (10)
  • L-TPS02 (13)
  • L-TPS03 (5)
  • L-TPS04 (10)
  • L-TPS05 (10)
  • L-TPS06 (7)
  • L-TPS07 (7)
  • L-TPS08 (7)
  • L-TPS09 (10)
  • L-TPS10 (8)
  • L-TPS11 (10)
  • L-TPS12 (1)
  • L-TPS13 (8)
  • L-TPS14 (2)
  • L-TPS15 (1)
  • L-TPS16 (7)
  • L-TPS17 (9)
  • L-TPS18 (9)
  • L-TPS20 (2)
  • L-TPS21 (6)
  • L-TPS22 (8)
  • L-TPS23 (12)
  • L-TPS24 (9)
  • L-TPS25 (2)
  • TPS01 (9)
  • TPS02 (10)
  • TPS03 (6)
  • TPS04 (5)
  • TPS05 (9)
  • TPS06 (9)
  • TPS07 (6)
  • TPS08 (12)
  • TPS09 (12)
  • TPS10 (5)
  • TPS11 (6)
  • TPS12 (6)
  • TPS13 (9)
  • TPS14 (6)
  • TPS15 (4)
  • TPS16 (9)
  • TPS17 (8)
  • TPS18 (9)
  • TPS20 (7)
  • TPS21 (10)
  • TPS22 (6)
  • TPS23 (6)
  • TPS24 (8)
  • TPS25 (4)
  • TPS26 (9)
  • TPS27 (1)
  • TPS30 (9)
  • TPS31 (4)
  • TPS32 (2)
  • TPS33 (10)
  • TPS34 (7)
  • TPS35 (5)
  • TPS36 (7)
  • TPS37 (9)
  • TPS38 (6)
  • TPS39 (9)
  • TPS40 (4)
  • TPS41 (9)
  • TPS42 (12)
  • TPS43 (9)
  • TPS44 (4)
  • TPS45 (2)
  • TPS46 (1)
  • TPS47 (9)
  • TPS48 (3)
  • TPS49 (7)
  • TPS50 (4)
  • TPS51 (2)
  • TPS52 (8)
  • TPS53 (4)
  • TPS54 (7)
  • TPS55 (6)
  • TPS56 (10)
  • TPS57 (4)
  • TPS58 (4)
  • TPS59 (11)
  • TPS60 (8)
  • TPS61 (6)
  • TPS62 (9)
  • TPS63 (9)
  • TPS64 (12)
  • TPS65 (12)
  • TPS66 (7)
  • TPS67 (10)
  • TPS68 (5)
  • TPS69 (4)
  • TPS70 (1)
  • TPS71 (7)
  • TPS72 (1)
  • TPS73 (8)
  • TPS74 (8)
  • TPS75 (7)
  • TPS76 (9)
  • TPS77 (6)
  • TPS78 (12)
  • TPS79 (2)
  • TPS80 (8)
  • TPS81 (6)
  • TPS82 (4)
  • TPS83 (3)
  • TPS84 (6)
  • TPS85 (7)
  • TPS88 (2)
  • TPS89 (2)
793 results
Thumbnail

D1.365 - Long-term course of NSAID tolerance in patients with cross-hypersensitivity presenting with respiratory symptoms

Thumbnail

D1.367 - Risk factors for immediate hypersensitivity reactions to rituximab

Thumbnail

D1.37 - Which Came First? Atopic Dermatitis or occupational Allergic Contact Dermatitis in a Surgeon with Tropomyosin-Driven IgE Cross-Reactivity

Thumbnail

D1.373 - Hypersensitivity to Biologic Therapies: Mechanism of Cross-reactivity

Thumbnail

D1.376 - Successful Desensitization with Temozolomide in a Patient with a Hypersensitivity Reaction to Temozolomide

Thumbnail

D1.377 - Folic Acid Allergy: A Rare Case

Thumbnail

D1.378 - Hypersensitivity During Continuous 5-Fluorouracil Infusion: Two Cases Successfully Managed With Desensitization

Thumbnail

D1.381 - Antibiotic Allergy De-labelling in Children: Outcomes of Drug Provocation Testing and Feasibility of Non-Specialist Pathways to de-labelling

Thumbnail

D1.382 - Vitamin K–Induced Anaphylaxis: A Case Series from a Tertiary Hospital in Manila, Philippines (2024–2025)

Thumbnail

D1.384 - Safe Sulfonamide Delabeling in HIV-Negative Adults: Real-World Evidence with TMP-SMX Oral Challenge and SULF-FAST

Thumbnail

D1.385 - Lamotrigine-induced Stevens-Johnson syndrome in a pediatric patient with Takayasu arteritis: the steroid paradox

Thumbnail

D1.387 - Long-term Follow-up Outcomes of Patients Undergoing Desensitization for Non-Immediate Hypersensitivity Reactions Associated with Lenalidomide

Thumbnail

D1.388 - Aspirin maintenance after boost with dupilumab in aspirin-exacerbated respiratory disease

Thumbnail

D1.39 - Oral Lichenoid Lesions Secondary to Contact Allergy to L-Carvone from Toothpaste: A Case Report

Thumbnail

D1.390 - Hypersensitivity Reactions to Biological Agents in a Tertiary Hospital: A 3.5-Year Retrospective Study

Thumbnail

D1.392 - Drug-Induced Hypersensitivity Syndrome Associated with β-Lactams and Hemophagocytic Lymphohistiocytosis: Overlapping Disorders or a Causal Relationship?

Thumbnail

D1.393 - Safety of Aspirin Oral Provocation in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Thumbnail

D1.394 - Functional AOC1 variants associated with reduced diamine oxidase activity mimicking multiple drug hypersensitivity and mast cell disorders

Thumbnail

D1.397 - Successfull rapid drug desensitization to cemiplimab in a patient with lung squamous cell carcinoma

Thumbnail

D1.398 - Safety Outcomes and Predictors of Clinically Significant Reactions in Positive Drug Provocation Tests: A 10-Year Tertiary-Center Cohort

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Current page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • …
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2026 EAACI
Made with   by CYIM